Phage therapy shows promise in treating tough Pseudomonas aeruginosa infections

A new international study conducted by the Israeli Phage Therapy Center (IPTC) led by Prof. Ran Nir-Paz at Hadassah Hebrew University Medical Center and Prof. Ronen Hazan of the Faculty of Dental Medicine at The Hebrew University of Jerusalem, using phage PASA16 on compassionate basis to treat tough Pseudomonas aeruginosa infections, has shown promising results with an 86.6% success rate.

Related Keywords

United States ,Israel ,Jerusalem ,Israel General ,American ,Israeli ,Megan Craig ,Ronen Hazan ,Israeli Phage Therapy Center ,Hadassah Hebrew University Medical Center ,Hebrew University Of Jerusalem ,Ran Nir Paz ,Dental Medicine ,Hebrew University ,Antibiotic ,Virus ,Bacteria ,Children ,Healthcare ,Hospital ,Infectious Diseases ,Medicine ,Icrobiology ,Rthopedic ,Athogen ,Research ,Surgery ,Herapeutics ,